Indian Diabetes Market Discussed in New IMARC Group Report Now Available at MarketPublishers.com

01 Apr 2013 • by Natalie Aster

LONDON – The Indian market for diabetes is the second largest market after China in terms of the number of people suffering from the disease. Bad nutritional history, the genetic susceptibility to diabetes, sedentary lifestyles entailed growth the incidence of diabetes in the country. Currently, there are about 63 million people suffering from diabetics in India, while the number is expected to hit an 87 million mark by 2030, with over 55% of patients coming from the urban regions.

The market for diabetes drugs and diagnostics is on the rise due to a steady growth in the healthcare expenditures in India. Through 2015, India’s diabetes market is set to increase at a CAGR of 22%. By 2015, the Indian diabetes market is likely to reach INR 6300 crore.

New report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” prepared by IMARC Group offers a complete analysis of the Indian diabetes market. The research discusses the key factors driving the market for diabetes in India, discloses market shares of the main players. Furthermore, the report includes the description of the disease, data on the market segmentation and current and historic market trends. The future prospects for the market up to 2018 are unveiled in the study.

Report Details:

Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics
Published: March, 2013
Pages: 50
Price: US$ 800.00

More New India Market Research Reports by IMARC Group Include:

More insightful market research reports by the publisher can be found at IMARC Group page.

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com